Evidence map›Paper›PMID 39300331›Full record

Observational studyBMC infectious diseases2024

Epidemiological, clinical and microbiological characteristics of patients with biliary tract diseases with positive bile culture in a tertiary hospital.

Tingting Liu, Moyan Li, Ling Tang, Bo Wang, Tingting Li, Ying Huang, Yuanhong Xu, Yajuan Li

Abstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Predictive value of platelet count-related ratios for severity in biliary Escherichia coli and Klebsiella pneumonia bloodstream infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  10. Article
  11. Article
  12. The First Case of Antimicrobial-ResistantInfection and drug resistance · 2025
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tingting LiuDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Moyan LiDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ling TangDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Bo WangDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Tingting LiDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ying HuangDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yuanhong XuDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China. xyhong1964@163.com.
Yajuan LiDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China. liyajuan@ahmu.edu.cn.

Funding

Natural Science Foundation of Anhui Province 9021138201Scientific Research Project of Universities in Anhui Province KJ2020A0170
6 · The paper itself

Abstract

purposeThe prevalence of biliary tract diseases, which are common gastrointestinal disorders, is steadily rising. If it progresses to sepsis or septic shock, it can endanger the patient's life. Therefore, it is crucial to promptly diagnose bacterial infection in individuals suffering from biliary diseases and comprehend the risk factors associated with infection. The objective of this study was to examine the types of bacteria present in the bile of patients with biliary tract diseases, assess any alterations in their susceptibility to antimicrobial agents, and identify the risk factors contributing to the development of infection in these patients. PATIENTS AND

methodsFrom June 2019 to November 2022, 317 patients of biliary tract diseases with positive bile culture were included in this hospital-based descriptive analysis. The hospital's computerized medical records were used to collect data on demographic information (including gender, age, and occupation), laboratory, and clinical findings, physical examination results, comorbidities, basic diseases, treatment history, complications, and in-hospital outcomes. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) principles.

resultsOf the 317 patients with positive biliary tract diseases, 247 had benign diseases and 70 had malignant diseases. Patients with benign disease experienced a higher prevalence of statistically significant symptoms such as abdominal pain (81.4% vs. 57.1%, P = 0.000), nausea (31.2% vs. 14.3%, P = 0.005), vomiting (30.0% vs. 12.9%, P = 0.004), and chills (10.9% vs. 2.9%, P = 0.039), while jaundice (12.6% vs. 37.1%, P = 0.000) was more common in patients with malignant disease. At the species level, Escherichia coli (105; 40.5%), Klebsiella pneumoniae (41; 15.8%), and Pseudomonas aeruginosa (30; 11.6%) were the most commonly found Gram-negative bacterial strains in biliary tract infection. Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were most susceptible to tigecycline, ertapenem and ceftazidime/avibactam, respectively.

conclusionGram-negative bacteria are the most commonly isolated biliary bacteria. Clinical doctors should pay attention to patients with malignant diseases with low hemoglobin, high total bilirubin and high alkaline phosphatase. Carbapenems, tigecycline, and minocycline are the recommended antibiotics for Enterobacteriaceae. In recent years, the proportion of enterococcus has gradually increased, and clinical attention should be paid to enterococcus infection. Linezolid and vancomycin were recommended for the treatment of Enterococci infections. Overall, this work can provide reference for clinical diagnosis, treatment and effective interventions.

Indexed as

Anti-Bacterial AgentsBileBiliary Tract DiseasesTertiary Care CentersAdultAgedAged, 80 and overBacteriaBacterial InfectionsFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedPrevalenceRisk FactorsAnti-Bacterial AgentsBile cultureBiliary tract diseasesEpidemiologicalMicrobiological characteristics

Identifiers

PMID39300331
PMCPMC11414084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.